The atorvastatin and ezetimibe combination market has grown 40% in a single year. The cumulative prescription amount of related generics increased over twofold and drove the market growth.

In particular, Jeil Pharmaceutical and Viatris Korea’s Lipitor Plus is rapidly increasing its influence in the market. Prescription sales of Lipitor Plus rose 4.6 times in one year and became the highest-performing product among all generics.

◆Prescipriton of Atozet generics rise 96% in a year…market share increases to 56%

According to the market research institution UBIST on the 7th, the outpatient prescription sales of the atorvastatin and ezetimibe combination had reached KRW 5